Memory-enhancing drug may improve exposure therapy for PTSD patients
November 3, 2011 in Psychology & Psychiatry
A memory-enhancing drug may improve the speed and effectiveness of prolonged exposure therapy for post-traumatic stress disorder (PTSD) patients, according to a new pilot study by psychologists at The University of Texas at Austin, the University of Washington and the University of Pennsylvania.
To lessen the time it takes for PTSD patients to recover, University of Texas at Austin psychology professors Michael Telch and Francisco Gonzalez-Lima, along with their team of researchers, are pairing prolonged exposure therapy with United States Pharmacopeia (USP) methylene blue.
In prolonged exposure therapy, patients repeatedly recount a fearful event. As the patients begin to look at the memory differently, the memory has less control over their lives.
The researchers believe the FDA-approved compound methylene blue, which significantly improved fear extinction in rats in an earlier study conducted in the Gonzalez-Lima Lab, will help strengthen memory that occurred during therapy sessions with PTSD patients. Normally, about two-thirds of PTSD patients treated with prolonged exposure therapy during ten 90-minute sessions no longer exhibit PTSD.
As part of the study, respondents take a placebo pill or a dose of USP methylene blue after a therapy session. The researchers theorize the drug will help patients recover faster and better in only six daily one-hour sessions.
Post-traumatic stress symptoms often emerge immediately after traumatic experiences, such as combat experience, abuse, rape, robbery, accidents and natural disasters. For most, these symptoms subside on their own soon after the trauma. However, about 30 percent of trauma victims go on to develop PTSD in which their trauma memories continue to haunt them and create significant distress and life impairment for months or years after the event.
Because prolonged, repeated recall of traumatic memories during behavior therapy stimulates new adaptive learning around the memories, the researchers predict that patients given a memory boost with USP methylene blue immediately after therapy sessions will make more lasting gains during therapy than those who do not take the medication.
Taken orally, the chemical properties of USP methylene blue affect regions of the brain, such as those stimulated after thinking about a memory.
Methylene blue easily crosses the blood-brain barrier and accumulates inside activated brain cells, Gonzalez-Lima says. Once inside the neurons, the substance zooms in on mitochondria the power house of the cell to keep it active and enable the brain cells to keep processing the memory.
Provided by
University of Texas at Austin
-
Exposure therapy may help prevent post-traumatic stress disorder
Jun 03, 2008 |
not rated yet |
0
-
'Trauma pill' could help those with PTSD
Jan 30, 2006 |
not rated yet |
0
-
Certain therapies appear beneficial in reducing PTSD symptoms in some trauma survivors
Oct 03, 2011 |
not rated yet |
0
-
Innovative virtual reality exposure therapy shows promise for returning troops
Feb 16, 2011 |
not rated yet |
0
-
Ecstasy could help patients with post-traumatic stress disorder
Mar 09, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Psychology & Psychiatry
12 hours ago |
4.7 / 5 (3) |
0
|
US psychiatry gets makeover in new manual
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
Psychology & Psychiatry
May 18, 2013 |
not rated yet |
1
Study reviews readmissions in inpatient psychiatric facilities
(HealthDay)—Most Medicare beneficiaries treated in inpatient psychiatric facilities (IPFs) exhibit characteristics associated with hospital readmission, according to a report prepared for the National Association ...
Psychology & Psychiatry
May 17, 2013 |
not rated yet |
0
Skydiving is never plane sailing
Skydivers show the same level of physical stress before every jump whether a first-timer or experienced jumper, say Northumbria researchers.
Psychology & Psychiatry
May 17, 2013 |
not rated yet |
0
|
Kids, especially boys, perceive sadness of depressed parents
Children of depressed parents pick up on their parents' sadness—whether mom or dad realizes their mood or not.
Psychology & Psychiatry
May 17, 2013 |
4.5 / 5 (2) |
1
|
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Alzheimer's leaves bilingual victims stranded in Canada
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...